That's a really great question.
There are a number of different therapies. As we get more data on the brain, we're seeing that it's not just one disease; it shows up differently in different people. Having a brain stimulation approach might work for some people, or having a drug might work with other people.
I think that's why we had so many failures before. We treated it as one disease and we treated it the same way in all people. To make an impact, we really need to have different avenues of approach and to understand the complexity of the brain across different people and different populations. There are a lot of new technologies and new approaches coming up.